This disclosure is protected under United States and International Copyright laws. ©VERATHON® Incorporated. All Rights Reserved. A portion of the disclosure of this patent document contains material which is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure, as it appears in the patent and Trademark Office patent file or records, but otherwise reserves all copyright rights whatsoever.
Embodiments of the invention pertain to the image processing of targeted regions of interest scanned by ultrasound transceivers.
Ultrasound imaging depending on Fast Fourier Transforms (FFT) may lack the needed spectral information to generate diagnostically useful images under certain circumstances. The deficiency inherent in some FFT procedures can be overcome by using other approaches.
Systems and methods utilizing artificial intelligence via a harmonics analysis kernel (HAK) algorithm using returning first and second echo wavelength harmonics that arise from differential and non-linear wavelength distortion and attenuation experienced by transiting ultrasound energy returning from a targeted region-of-interest (ROI). The HAK algorithm is non-parametric and is substantially less susceptible to modeling errors. Using the harmonic ratios with a sub-aperture algorithm provides diagnostically useful images.
The sub-aperture algorithms are substantially fast enough to be implemented in real time within the time constraints enforced by ultrasound scanning protocols to acquire organ size information using scanning modalities besides the original ultrasound B-mode images. The harmonic information is collected using a long interrogating pulse with a single fundamental frequency. The received signal is collected, analyzed for its spectrum information about the first and second harmonics. The ratio of these two harmonics provides the quantitative information on how much harmonics have been generated and attenuated along its propagation. The sub-aperture algorithm may be executed in non-parametric mode to minimize data modeling errors.
The file of this patent contains at least one drawing executed in color. Copies of this patent with color drawing(s) will be provided by the Patent and Trademark Office upon request and payment of the necessary fee. Embodiments for the system and method to develop, present, and use clarity enhanced ultrasound images is described below.
Particular embodiments described include a system and method to improve image clarity in ultrasound images that utilize an ultrasound transceiver receiving ultrasound energy returning from a targeted region of interest and producing a plurality of echoic signals. The region-of-interest may include an organ, an organ cavity, for example a bladder, or a portion of an organ or organ cavity. The echoic signals then receive signal processing via an executable algorithm configured to image the targeted region-of-interest from the echoic signals using at least one of a first harmonic, a second harmonic, and a fundamental frequency of the ultrasound energy. The algorithm generates a harmonic value that may then be plotted on a grid or render a map presentable on a computer display or other visual means. Alternate embodiments provide that the executable algorithm may be non-parametric and include a Harmonic Analysis Kernal (HAK). The HAK includes a window process, a Fast Fourier Transform process, an average process, a normalization of intensity process, a compensation-by-depth process, and a harmonic smoothing process to generate the harmonic values. A map of the harmonic values then may be coded, for example, by color-coding according to the magnitude of the harmonic value, to present an image of the region-of-interest.
Other systems, methods, and devices are configured for determining transducer functionality by using simulated body fluids, simulated body tissue, and combination simulated body fluids and body tissues for transducers having the characteristics of a 13 mm, 2.949 Mhz transducer in an ultrasound transceiver, for example the 9400 device developed by Verathon®, Inc. The transducer tests compare drive signal to produced signal in various environments (attenuating, non-attenuating, and a combination) and can also help us compare the produced signal to the received signal in the same various environments. These transducer tests help quantify the functionality of the 13 mm transducers maximize the determination of transducer precision and accuracy.
The ultrasound transceivers or DCD devices developed by Verathon®, Inc. (formerly Diagnostic Ultrasound Inc.) are capable of collecting in vivo three-dimensional (3-D) cone-shaped ultrasound images of a patient. Based on these 3-D ultrasound images, various applications have been developed such as bladder volume and mass estimation. The clarity of images from the DCD ultrasound transceivers depends significantly upon the functionality, precision, and performance accuracy of the transducers used in the DCD ultrasound transceivers.
During the data collection process initiated by DCD, a pulsed ultrasound field is transmitted into the body, and the back-scattered “echoes” are detected as a one-dimensional (1-D) voltage trace, which is also referred to as a RF line. After envelope detection, a set of 1-D data samples is interpolated to form a two-dimensional (2-D) or 3-D ultrasound image.
The handle 12 includes a trigger 14 that allows the user to initiate an ultrasound scan of a selected anatomical portion, and a cavity selector (not shown). The transceiver 10A also includes a transceiver dome 20 that contacts a surface portion of the patient when the selected anatomical portion is scanned. The dome 20 generally provides an appropriate acoustical impedance match to the anatomical portion and/or permits ultrasound energy to be properly focused as it is projected into the anatomical portion. The transceiver 10A further includes one, or preferably an array of separately excitable ultrasound transducer elements (not shown in
A directional indicator panel 22 includes a plurality of arrows that may be illuminated for initial targeting and guiding a user to access the targeting of an organ or structure within an ROI. In particular embodiments if the organ or structure is centered from placement of the transceiver 10A acoustically placed against the dermal surface at a first location of the subject, the directional arrows may be not illuminated. If the organ is off-center, an arrow or set of arrows may be illuminated to direct the user to reposition the transceiver 10A at a second or subsequent dermal location of the subject. The acrostic coupling may be achieved by liquid sonic gel applied to the skin of the patient or by sonic gel pads to which the transceiver dome 20 is placed against. The directional indicator panel 22 may be presented on the display 54 of computer 52 in harmonic imaging subsystems described in
Transceiver 10A may include an inertial reference unit that includes an accelerometer 22 and/or gyroscope 23 positioned preferably within or adjacent to housing 18. The accelerometer 22 may be operable to sense an acceleration of the transceiver 10A, preferably relative to a coordinate system, while the gyroscope 23 may be operable to sense an angular velocity of the transceiver 10A relative to the same or another coordinate system. Accordingly, the gyroscope 23 may be of conventional configuration that employs dynamic elements, or it may be an optoelectronic device, such as the known optical ring gyroscope. In one embodiment, the accelerometer 22 and the gyroscope 23 may include a commonly packaged and/or solid-state device. One suitable commonly packaged device may be the MT6 miniature inertial measurement unit, available from Omni Instruments, Incorporated, although other suitable alternatives exist. In other embodiments, the accelerometer 22 and/or the gyroscope 23 may include commonly packaged micro-electromechanical system (MEMS) devices, which are commercially available from MEMSense, Incorporated. As described in greater detail below, the accelerometer 22 and the gyroscope 23 cooperatively permit the determination of positional and/or angular changes relative to a known position that is proximate to an anatomical region of interest in the patient. Other configurations related to the accelerometer 22 and gyroscope 23 concerning transceivers 10A,B equipped with inertial reference units and the operations thereto may be obtained from copending U.S. patent application Ser. No. 11/222,360 filed Sep. 8, 2005, herein incorporated by reference.
The transceiver 10A includes (or if capable at being in signal communication with) a display 16 operable to view processed results from an ultrasound scan, and/or to allow an operational interaction between the user and the transceiver 10A. For example, the display 24 may be configured to display alphanumeric data that indicates a proper and/or an optimal position of the transceiver 10A relative to the selected anatomical portion. Display 16 may be used to view two- or three-dimensional images of the selected anatomical region. Accordingly, the display 16 may be a liquid crystal display (LCD), a light emitting diode (LED) display, a cathode ray tube (CRT) display, or other suitable display devices operable to present alphanumeric data and/or graphical images to a user.
Still referring to
To scan a selected anatomical portion of a patient, the transceiver dome 20 of the transceiver 10A may be positioned against a surface portion of a patient that is proximate to the anatomical portion to be scanned. The user actuates the transceiver 10A by depressing the trigger 14. In response, the transceiver 10 transmits ultrasound signals into the body, and receives corresponding return echo signals that may be at least partially processed by the transceiver 10A to generate an ultrasound image of the selected anatomical portion. In a particular embodiment, the transceiver 10A transmits ultrasound signals in a range that extends from approximately about two megahertz (MHz) to approximately about ten MHz. Ultrasound energies beyond 10 MHz may be utilized.
In one embodiment, the transceiver 10A may be operably coupled to an ultrasound system that may be configured to generate ultrasound energy at a predetermined frequency and/or pulse repetition rate and to transfer the ultrasound energy to the transceiver 10A. The system also includes a processor that may be configured to process reflected ultrasound energy that is received by the transceiver 10A to produce an image of the scanned anatomical region. Accordingly, the system generally includes a viewing device, such as a cathode ray tube (CRT), a liquid crystal display (LCD), a plasma display device, or other similar display devices, that may be used to view the generated image. The system may also include one or more peripheral devices that cooperatively assist the processor to control the operation of the transceiver 10A, such a keyboard, a pointing device, or other similar devices. In still another particular embodiment, the transceiver 10A may be a self-contained device that includes a microprocessor positioned within the housing 18 and software associated with the microprocessor to operably control the transceiver 10A, and to process the reflected ultrasound energy to generate the ultrasound image. Accordingly, the display 16 may be used to display the generated image and/or to view other information associated with the operation of the transceiver 10A. For example, the information may include alphanumeric data that indicates a preferred position of the transceiver 10A prior to performing a series of scans. In yet another particular embodiment, the transceiver 10A may be operably coupled to a general-purpose computer, such as a laptop or a desktop computer that includes software that at least partially controls the operation of the transceiver 10A, and also includes software to process information transferred from the transceiver 10A, so that an image of the scanned anatomical region may be generated. The transceiver 10A may also be optionally equipped with electrical contacts to make communication with receiving cradles 50 as illustrated in
As described above, the angular movement of the transducer may be mechanically effected and/or it may be electronically or otherwise generated. In either case, the number of lines 48 and the length of the lines may vary, so that the tilt angle φ sweeps through angles approximately between −60° and +60° for a total arc of approximately 120°. In one particular embodiment, the transceiver 10 may be configured to generate approximately about seventy-seven scan lines between the first limiting scan line 44 and a second limiting scan line 46. In another particular embodiment, each of the scan lines has a length of approximately 18 to 20 centimeters (cm). The angular separation between adjacent scan lines 48 (
The locations of the internal and peripheral scan lines may be further defined by an angular spacing from the center scan line 34B and between internal and peripheral scan lines. The angular spacing between scan line 34B and peripheral or internal scan lines may be designated by angle Φ and angular spacings between internal or peripheral scan lines may be designated by angle Ø. The angles Φ1, Φ2, and Φ3 respectively define the angular spacings from scan line 34B to scan lines 34A, 34C, and 31D. Similarly, angles Ø1, Ø2, and Ø3 respectively define the angular spacings between scan line 31B and 31C, 31C and 34A, and 31D and 31E.
With continued reference to
The transceiver 10C presents a similar transceiver display 16, housing 18 and dome 20 design as transceivers 10A and 10B, and is in signal communication to console 74 via signal cable 17. The console 74 may be pivoted from console base 72. The console 74 includes a display 76, detection and operation function panel 78, and select panel 80. The detection and operation function provide for targeting the bladder, allow user voice annotation recording, retrieval and playback of previously recorded voice annotation files, and current and previously stored 3D and 2D scans. In the display 76 is screenshot 76 having a targeting icon 79A with cross hairs centered in a cross sectional depiction of a bladder region. Other screen shots may appear in the display 76 depending on which function key is pressed in the function panel 78. A targeting icon screenshot 77B with a plurality of directional arrows may appear and flash to guide the user to move the transceiver 10C to center the bladder and can appear on either display 76 or display 16. The targeting icon screenshot 77B similar guides the user to place the transceiver 10C to center the bladder or other organ of interest as the directional indicator panel 22 depicted in
The information obtainable from the scanning transceivers 10A or 10B used in sub-systems 60A-60D are derived from ultrasound echoes that are converted to signals received from structures in the body. These ultrasound echo signals carry not only the frequencies of the original transmit pulse, but also include multiples, or harmonics of these frequencies. These linear components are used in conventional, fundamental B-mode imaging.
In contrast, non-linear effects cause the harmonic echo frequencies during the propagation of ultrasound through various mediums. For example, THI (tissue harmonic imaging) is based on the phenomenon wherein ultrasound signals are distorted while propagating through tissue with varying acoustic properties. However, THI is merely an imaging method that does not solve the bladder detection problem.
Harmonic information is hidden in the frequency domain and it is an effective indicator for harmonic build-up on each scan line at different depth, based on which bladder lines and tissue lines can be separated. For example, inside a bladder region, there is not enough reflection, so the attenuations of the first and second harmonics are low. Deep behind the bladder wall, both the first and the second harmonics can be attenuated, while the second harmonic can be attenuated much faster than the first one. As a result, harmonic information can be higher for a scan line which passes through a bladder, compared to a scan line that penetrates tissue only.
One way to use the harmonic information is to use relative change of the harmonic information around the 2nd harmonic frequency compared with response at fundamental frequency. The ratio (Goldberg Number) of the peak value around the 2nd harmonic and the peak value around the fundamental frequency is a suitable indicator for such change.
From the clinical data collected from an ultrasound device, it can be observed that its spectrum is very noisy. This holds true even when there is little or no noise presented within the data. The convolution theory indicates that it is hard to use conventional FFT method to get good spectral estimation, not to mention that the stationary assumption does not hold for this data. A robust harmonic processing algorithm enables such a device to have good harmonic estimation results.
The window-processing block 106 utilizes a signal processing technique that applies a series of numerical weight to the echo signals resulting in a sub-signal set. The sub-signal set utilizes the Tailor window, a processing algorithm that allows computational adjustments between the mainlobe width and sidelobe levels common with signals exhibiting edge discontinuities. Thereafter, the FFT is applied at block 108, and the results thereof normalized with regard to the first harmonic spectrum intensity by taking the first harmonic spectrum intensity average and dividing it by the second harmonic spectrum intensity average. These calculations are then compensated with the expectation that a predicted attenuation of 2.5 dB/cm occurs to the imaging and/or echoic ultrasound energies.
The resulting data segments from the deconvolution process can be either overlapping or non-overlapping. For each data segment (on a single radio frequency (RF) pulse ultrasound data line), a Taylor window is applied to reduce its sidelobes from the Fast Fourier Transform FFT 108. After the FFT 108, an average of the spectrum around the first and the second harmonic frequencies is obtained at process block 110. Next, the normalization or compensation process is applied at block 112 to obtain an average the harmonic ratios based on the following sub-algorithm:
In the above sub-algorithm, ‘Att_Comp’ is an attenuation compensation parameter (a value of 2.5 dB/cm can be used as and estimate from the clinical data). The ‘threshold’ is a parameter used to reject the data when they are too small. Ratio_low=−35 dB. In summary, the ‘normalization’ step can remove the data segments that are too weak, the compensation step can compensate the harmonic ratio loss in tissue, and the averaging step can provide a more robust ratio estimator. The final step may be a spatial smoothing of the harmonic ratios across the scan lines within a scan plane.
Clinical results obtained from a properly targeted scan in which the bladder is substantially centered are described in
The second harmonics from the FFT and the HAK profiles may be plotted in 2-D presentations to enhance the visual delineation of a bladder region within a given scan plane via a color-coding process. The color-coding process is illustrated in
While the preferred embodiment of the invention has been illustrated and described, many changes can be made without departing from the spirit and scope of the invention. For example, gelatinous masses may be used to modify synthetic tissue and combination fluid and tissue to further define and optimize the sub-aperture neural network algorithm. Accordingly, the scope of the invention is not limited by the disclosure of the preferred embodiment.
This application is a continuation-in-part of, claims priority to, and incorporates by reference in its entirety to U.S. patent application Ser. No. 11/968,027 filed Dec. 31, 2007. This application is a continuation-in-part of, claims priority to, and incorporates by reference in its entirety to U.S. patent application Ser. No. 11/926,522 filed Oct. 27, 2007. This application is a continuation-in-part of, claims priority to, and incorporates by reference in its entirety to U.S. patent application Ser. No. 11/925,887 filed Oct. 27, 2007. This application is a continuation-in-part of, claims priority to, and incorporates by reference in its entirety to U.S. patent application Ser. No. 11/925,896 filed Oct. 27, 2007. This application is a continuation-in-part of, claims priority to, and incorporates by reference in its entirety to U.S. patent application Ser. No. 11/925,900 filed Oct. 27, 2007. This application is a continuation-in-part of, claims priority to, and incorporates by reference in its entirety to U.S. patent application Ser. No. 11/925,850 filed Oct. 27, 2007. This application is a continuation-in-part of, claims priority to, and incorporates by reference in its entirety to U.S. patent application Ser. No. 11/925,843 filed Oct. 27, 2007. This application is a continuation-in-part of, claims priority to, and incorporates by reference in its entirety to U.S. patent application Ser. No. 11/925,654 filed Oct. 26, 2007. This application incorporates by reference in their entirety and claims priority to U.S. Provisional Patent Application Nos. 60/938,359 filed May 16, 2007; 60/938,371 filed May 16, 2007; and 60/938,446 filed May 16, 2007. All applications incorporated by reference in their entirety.
Number | Date | Country | |
---|---|---|---|
60938359 | May 2007 | US | |
60938371 | May 2007 | US | |
60938446 | May 2007 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11968027 | Dec 2007 | US |
Child | 12121726 | US | |
Parent | 11926522 | Oct 2007 | US |
Child | 11968027 | US | |
Parent | 11925887 | Oct 2007 | US |
Child | 11926522 | US | |
Parent | 11925896 | Oct 2007 | US |
Child | 11925887 | US | |
Parent | 11925900 | Oct 2007 | US |
Child | 11925896 | US | |
Parent | 11925850 | Oct 2007 | US |
Child | 11925900 | US | |
Parent | 11925843 | Oct 2007 | US |
Child | 11925850 | US | |
Parent | 11925654 | Oct 2007 | US |
Child | 11925843 | US |